Candriam Equities L Oncology Impact C/ LU1864484214 /
NAV07/11/2024 | Diferencia-0.0200 | Tipo de beneficio | Enfoque de la inversión | Sociedad de fondos |
---|---|---|---|---|
246.5500EUR | -0.01% | reinvestment | Equity Worldwide | Candriam ▶ |
NAV07/11/2024 | Diferencia-0.0200 | Tipo de beneficio | Enfoque de la inversión | Sociedad de fondos |
---|---|---|---|---|
246.5500EUR | -0.01% | reinvestment | Equity Worldwide | Candriam ▶ |